Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy

Japanese Journal of Clinical Oncology

Volumn 37, Issue 11, 2007, Pages 858-866

  Kim, Hunjung ^a   Kim, Woochul ^b   Lee, Mijo ^b   Song, Eunseop ^b   Loh, John J K ^b  

^a Dongguk University Gyeongju Hospital   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Cervical cancer; MRI; Tumor volume; Uterine body invasion

Indexed keywords

CISPLATIN;

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPH NODE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 37149040641     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym109     Document Type: Article

References (51)

1. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
2. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictor of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 1992;69:1750-8.
3. Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW, Jr, Hatch KD. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 1985;66:569-74.
4. Hopkins MP, Morley GW. Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol 1991;164:1520-7.
5. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Onocol Biol Phys 1994;29:9-16.
6. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volume try. Cancer 1998;70:648-55.
7. Kovalic JJ, Perez CA, Grigsby PW, Lockett M. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991;21:905-10.
8. Perez CA, Camel HM, Askin F, Breaux S. Endometrial extension of carcinoma of the uterine cervix: A prognostic factor that may modify staging. Cancer 1981;48:170-80.
9. Fagundes H, Perez CA, Grisby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1992;24:197-204.
10. Noguchi H, Shiozawa I, Kitahara T, Yamazaki T, Fukuta T. Uterine body invasion of carcinoma of the uterine cervix as seen form surgical specimens. Gynecol Oncol 1988;30:173-82.
11. Hope AJ, Saba P, Grigsby PW. FDG-FET in carcinoma of the uterine cervix with endometrial extension. Cancer 2006; 106:196-200.
12. Averette HE, Ford JH, Dudan RC, Girtanner RE, Hoskins WJ, Lutz MH, Staging of cervical cancer. Clin Obstet Gynecol 1975;18:215-32.
13. Brunschwig A. The surgical treatment of cancer of the cervix: Stage I and II. AJR 1968;102:147-51.
14. Heyman J, Kottmeier HL, Segerdahl CO, An investigation of the reliability of stage grouping in cancer of the uterine cervix. Acta Obstet Gynecol Scand 1953;32:65-79.
15. Burghardt E, Hofmann HM, Ebner F, Haas J, Tamussino K, Justich E. Magnetic resonance imaging in cervical cancer: A basis for objective classification. Gynecol Oncol 1989;33:61-7.
16. Subak L, Hricak H, Powell C, Azizi L, Stern J. Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995:86;43-50.
17. Mayr NA, Yuh WT, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997:39;395-404.
18. 2 measurement and histology. J Magn Reson Imag 1994;4:779-86.
19. Hricak H. Quivey J, Campos Z, Gildengorin V, Hindmarsh T, Bis K, Stern J, Phillips T. Carcinoma of the cervix: Predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993:27;791-801.
20. Narayan K, McKenzie A, Fisher R, Susil B, Jobing T, Bernshaw D. Estimation of tumor volume in cervical cancer by magnetic resonance imaging. Am J Clin Oncol 2003;26:163-8.
21. Hofman HM, Ebner F, Haas J, et al. Magnetic resonance imaging in clinical cervical cancer: Pretherapeutic tumor volumetry. Baillieres Clin Obstet Gynaecol 1988;2:789-802.
22. Kilcheski TS, Arger PH, Mulhem CBJ, Coleman BG, Kressel HY, Mikuta JI. Role of computed tomography in the presurgical evaluation of carcinoma of the cervix. J Comput Assist Tomogr 1981;5:378-83.
23. Vas W, Wolverson M, Freel J, Salimi Z, Sundaram M. Computed tomography in the pretreatment assessment of carcinoma of the cervix. J Comput Tomogr 1985;9:359-68.
24. Kim SH, Choi BI, Lee HP, Kang SB, Choi YM, Han MC, Kim CW. Uterine cervical carcinoma: Comparison of CT and MR findings. Radiology 1990;175:45-51.
25. Greco A, Mason P, Leung AWL, Dische S, Mclndoe GAJ, Anderson MC. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radio 1989;40:401-5.
26. Rubens D, Thornbury JR, Angel C, Stoler MH, Weiss SL, Lerner RM, Beecham J. Stage IB cervical carcinoma: Comparison of clinical, MR, and pathologic staging. AJR 1998; 150:135-8.
27. Sironi S, Belloni C, Taccagni G, DelMaschio A. Carcinoma of the cervix: Value of MR imaging in detecting parametrial involvement. AJR 1991;156:753-6.
28. Toita T, Kakinohana Y, Shinzato S, et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys 1999;43:777-82.
29. Hricak H, Lacey CG, Sandles LG, et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988;166:623-31.
30. Oellinger JJ, Blohmer JU, Michniewicz K, et al. Pre-operative staging of cervical cancer: Comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynackol 2000;122:82-91.
31. Manfredi R, Maresca G, Smaniotto D, et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1998;209: 819-24.
32. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69:2796-806.
33. Kodaira T, Fuwa N, Kamata M, et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: Are all patients with stage II disease suitable candidate for chemoradiotherapy? Int J Radiat Oncol Biol Phys 2002;52:627-36.
34. Kodaira T, Fuwa N, Toita T, et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:769-77.
35. Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer 2006;16:623-30.
36. Narayan K, McKenzie AF, Hicks RJ, et al. Relation between FIGO stage, primary tumor volume, and presnece of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer 2003;13:657-63.
37. Kamura T, Shigematsu T, Kaku T, Shimamoto T, Saito T, Sakai K, et al. Histopathologic factor influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand 1999;78:452-7.
38. Noguchi H, Shiozawa K, Tsukamoto T, Tsukahara Y, Iwai S, Fukuta T. The postoperative classification for uterine cervical cancer and its clinical evaluation. Gynecol Oncol 1893:16:219-31
39. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical patbologic spread patterns of endometrial cancer. A Gynecologic Onoology Group Study. Cancer 1987;60(8 Suppl): 2035-41.
40. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-75.
41. Finan MA, DeCesare S, Fiorica JV, et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Dose the new staging system predict morbidity and survival? Gynecol Oncol 1996;62:139-47.
42. Zreik TG, Chambers JT, Chambers SK. Phrametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancer. Obstet Gynecol 1996;87:741-6.
43. Delgado G, Bundy B, Fowler WC, et al. A prospective surgical pathological study of stage I squamous carcinoma of cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1989; 35:314-22.
44. Rutledge FN, Mitchell MF, Nunsell S, et al. Youth as a prognostic factor in carcinoma of the cervix: A matched analysis. Gynecol Oncol 1992;44:123-30.
45. Fyles; AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis. Radiother Oncol 1995;35:107-17.
46. Delaloye JF, Pampallona S, Coucke PA, et al. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 1996;64:201-5.
47. Reagan JW, Fu YS. Histologic types and prognosis of cancers of the uterine cervix. Int J Radiat Oncol Biol Phys 1979;5:1015-20.
48. Wentz WB, Reagan JW. Survival in cervical cancer with respect to cell type. Cancer 1959;12:384-8.
49. Goellner JR. Carcinoma of the cervix: Clinicopathologic correlation of 196 cases. Am J Clin Pathol 1976;66:775-85.
50. Gunderson LL, Weems WS, Hebertson RM, et al. Correlation of histopathology with clinical results following radiation therapy for carcinoma of cervix. AJR Am J Roentgenol Radium Ther Nucl Med 1974;l20:74-87.
51. Crissman JD, Budbraja M, Aron BS, et al. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 1987;6:97-103.